Fluvastatin prevents the development of arthritis in env-pX rats via up-regulation of Rho GTPase-activating protein 12-Reference-Cited by-同舟云学术

Fluvastatin prevents the development of arthritis in env-pX rats via up-regulation of Rho GTPase-activating protein 12

Published:2020-08 Issue: Volume:115 Page:104454
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Tanimura Shun,Nishida Mutsumi,Horie Tatsunori,Kamishima Tamotsu,Matsumoto Hitomi,Morimura Yutaka,Nishibata Yuka,Masuda Sakiko,Nakazawa Daigo,Tomaru Utano,Atsumi Tatsuya,Ishizu Akihiro

Funder

Takeda Pharmaceutical Co., Ltd

hugai Pharmaceutical Co., Ltd

AbbVie, Inc

Daiichi Sankyo Co., Ltd

Astellas Pharma, Inc

AYUMI Pharmaceutical Corp

Asahi Kasei Pharma Corporation

Eisai Co., Ltd.

Mitsubishi Tanabe Pharma Co

Takeda Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd

Bristol-Myers Squibb Co

Daiichi Sankyo Co., Ltd.

UCB Japan Co., Ltd

Novartis Co

Janssen Pharmaceutical K.K., Asahi Kasei Pharma Corporation

Eisai Co., Ltd

Alexion, Inc

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference36 articles.

1. Protective effects of simvastatin and hesperidin against complete Freund’s adjuvant-induced rheumatoid arthritis in rats;Ahmed;Pharmacology,2015

2. Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment;Akiyama;Clin. Rheumatol.,2015

3. Effects of simvastatin, ezetimibe, and their combination on histopathologic alterations caused by adjuvant-induced arthritis;Barbosa;Inflammation.,2014

4. Pleiotropic effects of statins: new therapeutic targets in drug design;Bedi;Naunyn Schmiedeberg’s Arch. Pharmacol.,2016

5. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice;Biswas;J. Clin. Invest.,2010